Company Name: Alkermes Plc.

Alkermes Plc. is a biopharmaceutical company. The company is engaged in the development and commercialization of treatments for central nervous system disorders. The company’s product portfolio includes both marketed and developmental products for several central nervous system disorders including:

• Addiction
• Depression
• Multiple sclerosis
• Schizophrenia

Ticker Symbol: ALKS (NASDAQ)

Company Website: www.alkermes.com

Social Media: Alkermes LinkedIn Page

Headquarters: Dublin, Ireland